Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes

Published 2009 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes
Authors
Keywords
-
Journal
INDIAN JOURNAL OF PHARMACOLOGY
Volume 41, Issue 4, Pages 197
Publisher
Medknow
Online
2009-09-26
DOI
10.4103/0253-7613.56070

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.